Preemptive therapy for the prevention of cytomegalovirus disease following heart transplantation directed by PP65 antigenemia

By Villa M.   Lage E.   Ballesteros S.   Canas E.   Sanchez M.   Ordonez A.   Borrego J.M.   Hinojosa R.   Cisneros J.M.  

Transplantation Proceedings, Vol. 35, Iss. 2, 2003-03 ,pp. : 732-734

Elsevier

Access to resources Recommend Favorite

Prophylaxis of cytomegalovirus disease with intravenous ganciclovir in renal transplantation

By Sancho A.   Gorriz J.L.   Crespo J.F.   Avila A.   Alcaraz M.J.   Garca Ramos J.L.   Pallardo L.M.  

Transplantation Proceedings, Vol. 31, Iss. 6, 1999-09 ,pp. : 2337-2338

Elsevier

Access to resources Recommend Favorite

Ganciclovir-related neutropenia after preemptive therapy for cytomegalovirus infection: comparison between cord blood and bone marrow transplantation

By Tomonari Akira  

Annals of Hematology, Vol. 83, Iss. 9, 2004-09 ,pp. : 573-577

Springer Publishing Company

Access to resources Recommend Favorite

Preemptive oral ganciclovir therapy versus prophylaxis to prevent symptomatic cytomegalovirus infection after kidney transplantation

By Jung C.   Engelmann E.   Borner K.   Offermann G.  

Transplantation Proceedings, Vol. 33, Iss. 7, 2001-11 ,pp. : 3621-3623

Elsevier

Access to resources Recommend Favorite

Preemptive and prophylactic ganciclovir therapy for CMV infection in heart transplant patients

By Paniagua M.J.   Crespo-Leiro M.G.   Rodriguez J.A.   Fojon S.   Zuniga M.C.   Canizares A.   Rey R.   Cuenca J.J.   Juffe A.   Castro-Beiras A.  

Transplantation Proceedings, Vol. 31, Iss. 6, 1999-09 ,pp. : 2528-2529

Elsevier

Access to resources Recommend Favorite